Company / Revenue
ALX ONCOLOGY HOLDINGS INC Revenue History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
-
FY2022
5-year range
$0 / $4.8M
FY2020-FY2022
Trend
-100.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $2M to $0 over the past 2 years.
Revenue over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, revenue decreased 100.0% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $0 | -100.0% |
| FY2021 | $4.8M | +132.0% |
| FY2020 | $2.1M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026